The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12
- 5 June 2009
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 28 (4) , 445-453
Abstract
Summary In this study, we characterized the effects of LA-12 on tumor cell lines possessing wild type p53 and on p53-deficient/mutant cell lines and the results were compared to those obtained using cisplatin. We have determined changes of p53 levels, of its transcriptional activity, of its posttranscriptional modifications and the effect of the treatment on the cell cycle, on the induction of apoptosis and on gene expression. LA-12 induces weak accumulation of both transcriptionally active p53 tumor suppressor and of p21WAF1/CIP1 protein. LA-12 and cisplatin also significantly differ in their effects on apoptosis and cell cycle and on gene expression spectra in studied cell lines. LA-12 induces higher apoptosis levels in comparison with those induced by cisplatin, especially in p53-deficient H1299 cells and in MCF-7DD cells with transcriptionally inactive p53. We suggest that LA-12-mediated apoptosis is not fully dependent on p53. This confirms the therapeutic potential of LA-12 as a more potent cytostatic agent for both tumor cells expressing wild type p53 and for p53-deficient or mutant cells.Keywords
This publication has 33 references indexed in Scilit:
- The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatinAnti-Cancer Drugs, 2008
- Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatinInvestigational New Drugs, 2007
- Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cellsGynecologic Oncology, 2006
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998
- DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 siteOncogene, 1998
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- p53: puzzle and paradigm.Genes & Development, 1996
- Characterisation of Epitopes on Human p53 using Phage-displayed Peptide Libraries: Insights into Antibody-Peptide InteractionsJournal of Molecular Biology, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993